Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors.
Saraiya B, Chugh R, Karantza V, Mehnert J, Moss RA, Savkina N, Stein MN, Baker LH, Chenevert T, Poplin EA.
Saraiya B, et al. Among authors: stein mn.
Invest New Drugs. 2012 Feb;30(1):258-65. doi: 10.1007/s10637-010-9504-5. Epub 2010 Aug 10.
Invest New Drugs. 2012.
PMID: 20697775
Free PMC article.
Clinical Trial.